TMPRSS2
Basic information
Region (hg38): 21:41464300-41531116
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMPRSS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 12 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 4 | |||||
Total | 0 | 0 | 13 | 1 | 11 |
Variants in TMPRSS2
This is a list of pathogenic ClinVar variants found in the TMPRSS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-41466152-G-C | not specified | Uncertain significance (Nov 20, 2024) | ||
21-41467734-C-T | TMPRSS2-related disorder | Likely benign (Apr 01, 2025) | ||
21-41467772-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
21-41467856-T-G | not specified | Uncertain significance (May 13, 2024) | ||
21-41468466-A-T | not specified | Uncertain significance (May 17, 2023) | ||
21-41468486-CTG-C | Prostate cancer | Uncertain significance (-) | ||
21-41470696-G-A | TMPRSS2-related disorder | Likely benign (Jul 16, 2023) | ||
21-41471908-C-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
21-41471962-G-A | not specified | Likely benign (Mar 06, 2025) | ||
21-41471981-T-C | not specified | Likely benign (Dec 11, 2023) | ||
21-41473377-C-A | not specified | Uncertain significance (Dec 14, 2022) | ||
21-41473432-C-T | Benign (Mar 29, 2018) | |||
21-41473446-C-T | not specified | Uncertain significance (Aug 23, 2021) | ||
21-41473479-T-C | not specified | Uncertain significance (Sep 07, 2022) | ||
21-41473493-C-A | not specified | Uncertain significance (Oct 18, 2021) | ||
21-41479207-G-A | Benign (May 23, 2018) | |||
21-41480507-C-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
21-41480508-G-A | Benign (Dec 31, 2019) | |||
21-41480570-C-T | Associated with severe COVID-19 disease | Benign (Feb 26, 2021) | ||
21-41494370-G-A | Benign (Dec 31, 2019) | |||
21-41494405-G-A | Benign (Jan 01, 2024) | |||
21-41494421-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
21-41494461-A-C | Benign (Jul 27, 2018) | |||
21-41494495-G-A | Benign (Apr 17, 2018) | |||
21-41494500-C-T | not specified | Uncertain significance (Jan 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TMPRSS2 | protein_coding | protein_coding | ENST00000398585 | 14 | 66566 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.40e-10 | 0.880 | 125696 | 0 | 52 | 125748 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.399 | 303 | 323 | 0.938 | 0.0000197 | 3428 |
Missense in Polyphen | 108 | 126.63 | 0.85288 | 1357 | ||
Synonymous | 0.758 | 132 | 144 | 0.919 | 0.0000109 | 1013 |
Loss of Function | 1.81 | 20 | 30.9 | 0.648 | 0.00000132 | 358 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000490 | 0.000489 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000462 |
European (Non-Finnish) | 0.000300 | 0.000299 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000198 | 0.000196 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Serine protease that proteolytically cleaves and activates the viral spike glycoproteins which facilitate virus- cell membrane fusions; spike proteins are synthesized and maintained in precursor intermediate folding states and proteolysis permits the refolding and energy release required to create stable virus-cell linkages and membrane coalescence. Facilitates human SARS coronavirus (SARS-CoV) infection via two independent mechanisms, proteolytic cleavage of ACE2, which might promote viral uptake, and cleavage of coronavirus spike glycoprotein which activates the glycoprotein for cathepsin L- independent host cell entry. Proteolytically cleaves and activates the spike glycoproteins of human coronavirus 229E (HCoV-229E) and human coronavirus EMC (HCoV-EMC) and the fusion glycoproteins F0 of Sendai virus (SeV), human metapneumovirus (HMPV), human parainfluenza 1, 2, 3, 4a and 4b viruses (HPIV). Essential for spread and pathogenesis of influenza A virus (strains H1N1, H3N2 and H7N9); involved in proteolytic cleavage and activation of hemagglutinin (HA) protein which is essential for viral infectivity. {ECO:0000269|PubMed:21068237, ECO:0000269|PubMed:21325420, ECO:0000269|PubMed:23536651, ECO:0000269|PubMed:23966399, ECO:0000269|PubMed:24027332, ECO:0000269|PubMed:24227843}.;
- Pathway
- Influenza A - Homo sapiens (human);Prostate cancer - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Coregulation of Androgen receptor activity;Regulation of Androgen receptor activity
(Consensus)
Recessive Scores
- pRec
- 0.195
Intolerance Scores
- loftool
- 0.166
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.75
Haploinsufficiency Scores
- pHI
- 0.293
- hipred
- Y
- hipred_score
- 0.589
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0651
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Tmprss2
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; immune system phenotype; respiratory system phenotype; neoplasm;
Gene ontology
- Biological process
- proteolysis;receptor-mediated endocytosis;protein autoprocessing;positive regulation of viral entry into host cell
- Cellular component
- plasma membrane;integral component of plasma membrane;extracellular exosome
- Molecular function
- serine-type endopeptidase activity;scavenger receptor activity;protein binding;serine-type peptidase activity